BAMS
ACHN

Bellevue Asset Management (Switzerland)’s Achillion Pharmaceuticals ACHN Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$4.53M Hold
420,000
– – 0.69% 51
2015
Q3 		$2.9M Buy
420,000
+44,000
+12% +$358K 0.47% 65
2015
Q2 		$3.33M Sell
376,000
-70,000
-16% -$662K 0.46% 69
2015
Q1 		$4.4M Buy
+446,000
New +$5.57M 0.61% 56

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s ACHN Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its Achillion Pharmaceuticals (ACHN) position steady in Q4 2015 at 420,000 shares worth $4.53M. The position accounts for 0.69% of the portfolio, ranked #51.

Bellevue Asset Management (Switzerland) first reported a position in ACHN in Q1 2015 and has held it in 4 quarters since. 152 funds tracked by Wall St. Rank hold ACHN as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 420,000 shares of Achillion Pharmaceuticals worth $4.53M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) left its Achillion Pharmaceuticals share count unchanged in Q4 2015.
  • Achillion Pharmaceuticals made up 0.69% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #51 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Achillion Pharmaceuticals in Q1 2015 and has held it in 4 quarters since.
  • 152 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.